Glimith MF 4mg/500mg Tablet SR
By Glimith-MF
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(4mg) + Metformin(500mg)

Manufacturer - Johnlee Pharmaceuticals Pvt Ltd
42/44, Babu Genu Road, Shop No. 06, 2nd Floor, Om Shanti Co-op Housing Society, Kalbadevi Road, Mumbai-400002. (India)

Expires on or after
September, 2025

liver
When it comes to your liver health, it's important to use Glimith MF 4mg/500mg Tablet SR with caution if you have liver disease. Your doctor may need to adjust the dose accordingly, so consulting them is crucial. For patients with mild to moderate liver disease, Glimith MF 4mg/500mg Tablet SR is usually initiated at a low dose. However, it is not advised for use in individuals with severe liver disease. Keeping your liver condition in mind, always seek guidance from your healthcare provider before starting or continuing Glimith MF 4mg/500mg Tablet SR.

kidney
Glimith MF 4mg/500mg Tablet SR requires caution in patients with kidney disease. Dosage adjustment may be necessary, so consult your doctor. Avoid in severe kidney disease; monitor kidney function regularly during use.

alcohol
It is unsafe to drink alcohol while taking Glimith MF 4mg/500mg Tablet SR.

driving
When using Glimith MF 4mg/500mg Tablet SR, avoid driving if you experience symptoms of low or high blood sugar that can affect your focus and reaction time. This could impact your ability to drive safely.

pregnancy
Glimith MF 4mg/500mg Tablet SR may not be safe to use during pregnancy. Limited human studies and animal studies show potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before using Glimith MF 4mg/500mg Tablet SR during pregnancy.

breastfeeding
Glimith MF 4mg/500mg Tablet SR is not safe to use while breastfeeding as it may harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹65
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024